NEW YORK (GenomeWeb News) – The universities that make up the Big Ten athletic conference in the US have shed their rivalries and banded together to harness their biomedical science resources in a new cancer research consortium.

The Big Ten Cancer Research Consortium aims to leverage the infrastructures, expertise, and clinical facilities available in these universities' cancer centers in joint oncology trials, the University of Michigan Health System said today. The consortium plans to use molecular diagnostics to study how cancers work and how to treat them.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.